Funding
← Back to your selection

Gaingels

Activity from announced rounds

Activity in this selectionOct 22, 2026 · AI · Jul 25, 2026

Gaingels co-invests alongside venture leads in companies committed to diverse and inclusive teams, spanning seed through growth and pre-IPO rounds across technology, healthcare and consumer markets.

Its investor community includes LGBTQ+ people and allies, extending representation within the ownership of venture-backed companies. Portfolio companies work with its Gaingels Letter commitments and Venture Inclusion programme on building more inclusive organisations.

A board access programme provides free recruitment advice for diverse board members and observers. This gives founders a practical governance resource alongside a co-investment partner for a round led by another venture firm.

Sources
Rounds participated in
4
Confirmed lead rounds
0
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$88M
3 disclosed · full round size, not this investor’s share

By stage

Series B2
Seed1
Undisclosed1

By primary sector

Biotech1
Fintech1
Healthtech1
Space tech1

By country

United States4

Rounds

4 in this selection
Satlyt

Software that lets satellite operators run additional applications and AI workloads on existing spacecraft.

$8MSeed
Participant
Superluminal Medicines

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

$60MSeries B
Participant
Standard Metrics

AI-driven portfolio management platform for VC and private equity firms

$20MSeries B
Role not disclosed